The characterization of PrecisA Monoclonals starts with an extensive literature search to select the most accurate, relevant, and clinically significant tissues to use for immunohistochemistry (IHC) characterization. Our product catalog provides IHC application data obtained from several tissue types.
Positively stained tissue is displayed together with negative control and clinical cancer tissue when relevant.
The characterization for Western blot (WB) data follows that same working procedure and starts with a profound literature search to find the best matching lysate. Each PrecisA Monoclonal antibody is supplied with the most relevant characterization data for its specific target.